XXII "is committed to working collaboratively with the FDA to demonstrate that our Very Low Nicotine cigarettes and our Low Tar-to-Nicotine Ratio cigarettes are legitimate – and enormously important – modified risk tobacco products.”
So- how much might Philip Morris or Reynolds Tobacco pay for XXII which is heavily patented in plant genetics....? Especially after FDA has pulled some of their "modified risk" products from the shelves?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.